Lung Cancer

Lung cancer is the world's most common cancer and kills more people than any other cancer. In 2008, approximately 1.52 million new cases of lung cancer were diagnosed worldwide, with 1.31 million people dying from the disease.(14) In the United States, an estimated 161,840 deaths, accounting for 29 percent of all cancer deaths, occurred in 2008, according to the American Cancer Society (ACS).

Lung Cancer

Lung cancer is a common and very serious form of cancer, with more than 40,000 people diagnosed with the condition each year in the UK. The symptoms of lung cancer do not present in the early stages, but when symptoms do eventually present, they usually include the following:

Lung Cancer Causes

Lung Cancer Symptoms

Lung Cancer Diagnosis

Epidemiology of Lung Cancer

Lung Cancer Treatments

Lung Cancer Research

Lung Cancer Questions

How to Prevent Lung Cancer

Lung Cancer Genetics

Lung Cancer Pathogenesis

What Causes Lung Cancer in Non-Smokers?

See more featured articles »

Lung Cancer: Radiotherapy and Chemotherapy

Types of Lung Cancer Surgery

Lymph Nodes in Lung Cancer

Pulmonary Resection in Lung Cancer

Palliative and End-of-Life Care in Lung Cancer

Secondary Lung Cancer

Carcinogens in Cigarette Smoke

Lung Cancer Screening Procedure

Lung Cancer and Electrolyte Imbalances

Lung Cancer Risk Factors

Everything You Need to Know About Giving Up Cigarettes

Immunotherapy: The Future of Lung Cancer Treatment?

Lung Plethysmography Procedure

Pulmonary Transplant (Lung Transplant)

What are the Survival Rates for Lung Cancer?

Exploring Diversity in Lung Cancer: Impact on Incidence, Prognosis, and Treatment Strategies

Lung Cancer in Women: Understanding the Increasing Risk

Latest Lung Cancer News and Research

WIN Consortium revolutionizing precision oncology for cancer patients

A new precision oncology paper was published in Oncotarget, Volume 16, on March 12, 2025, titled "Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients."

18 Mar 2025

AI-based neural network revolutionizes cancer treatment predictions

A first-of-its-kind artificial intelligence (AI)-based neural network can rapidly analyze and interpret millions of cells from a patient sample, predicting molecular changes in the tissue.

18 Mar 2025

A global movement to address the health impacts of air pollution

In an unprecedented show of unity, more than 47 million health professionals, patients, advocates, representatives from civil society organizations, and individuals worldwide have signed a resounding call for urgent action to reduce air pollution and to protect people's health from its devastating impacts.

18 Mar 2025

Eating by the book: French dietary guidelines linked to lower mortality risk

Higher adherence to the 2017 French dietary guidelines is linked to lower mortality risk, particularly for cardiovascular and some cancer deaths, though lung cancer risk trends reversed at high adherence levels.

17 Mar 2025

Yale research supports MRD detection for post-treatment lung cancer care

In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that measures the presence of cancer-derived molecules in the blood of patients with lung cancer years after their treatment.

17 Mar 2025

Combination of RAS inhibition and immunotherapy provides breakthrough for pancreatic cancer

Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept pancreatic cancer at bay in preclinical models for significantly longer than the same targeted therapy by itself, according to researchers from the Perelman School of Medicine at the University of Pennsylvania and Penn Medicine's Abramson Cancer Center.

14 Mar 2025

Social advantage reduces risk of age-related diseases and slows aging

People with favorable socioeconomic conditions, such as high incomes or education levels, face a reduced risk of age-related diseases and show fewer signs of biological aging than peers of the same age, finds a new study led by University College London (UCL) researchers.

14 Mar 2025

Study shows impact of statins and aspirin on muscle health in smokers

For current and former smokers, statins may reduce the amount of chest muscle loss, while aspirin may contribute to increased chest muscle loss, according to a new study.

13 Mar 2025

New treatment option for advanced thymic carcinoma shows promise

Thymic epithelial tumors are a rare group of malignancies originating in the thymus gland, that includes thymoma and thymic carcinoma.

12 Mar 2025

Breast cancer deaths expected to fall in the EU and UK by 2025 across most age groups

Death rates from breast cancer will fall in 2025 in every age group in the EU and the UK apart from in EU patients aged 80 years and older. In these older patients, overall mortality rates from the disease are predicted to rise by nearly 10% in 2025.

12 Mar 2025

Emergency room downtime can boost cervical cancer screenings, study shows

A University of Rochester Medical Center study showed that downtime in the emergency room can have a potential upside for women who are behind on cervical cancer screenings, which is a nationwide problem.

11 Mar 2025

Wildfires increase length of stay for lung cancer surgery patients

Due to the physical, psychological, and socioeconomic consequences of a cancer diagnosis and treatment, people with cancer are especially vulnerable during extreme weather events like hurricanes, tornadoes, and wildfires, which are becoming more common and damaging with climate change.

11 Mar 2025

Environmental factors and genes play key role in cancer development

A new editorial was published in Oncotarget, Volume 16, on March 10, 2025, titled "EXPOSOMES and GENES: The duo influencing CANCER initiation and progression."

11 Mar 2025

Machine learning models fall short in predicting in-hospital mortality

It would be greatly beneficial to physicians trying to save lives in intensive care units if they could be alerted when a patient's condition rapidly deteriorates or shows vitals in highly abnormal ranges.

11 Mar 2025

Breakthrough drug combination targets KRAS mutation in lung cancer

A breakthrough in lung cancer treatment may be on the horizon. Scientists at VCU Massey Comprehensive Cancer Center have uncovered a powerful combination therapy leveraging sotorasib-an FDA-approved drug in the market-and an experimental drug called FGTI-2734, which could make precision medicine more effective for patients with a highly resistant form of lung cancer.

10 Mar 2025

Walking more steps and exercise linked to lower risk of death in postmenopausal cancer survivors

Among postmenopausal women with a history of cancer, taking more daily steps and engaging in moderate-to-vigorous physical activity were both associated with a significantly reduced risk of death from cardiovascular disease, according to preliminary research presented at the American Heart Association's Epidemiology and Prevention | Lifestyle and Cardiometabolic Health Scientific Sessions 2025.

10 Mar 2025

Unraveling the genetic differences between LUAD and LUSC in lung cancer

Lung cancer remains one of the leading causes of cancer-related mortality, with lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) representing the most prevalent subtypes of non-small cell lung cancer (NSCLC).

8 Mar 2025

Targeted nanoparticles show promise in preventing pancreatic cancer spread to the liver

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced stages when the disease has already spread, or metastasized.

5 Mar 2025

AI successfully reduces workload in lung cancer screening

A new study by researchers from the University of Liverpool and the Research Institute for Diagnostic Accuracy, Netherlands, has demonstrated that artificial intelligence (AI) can significantly improve the efficiency of lung cancer screening.

4 Mar 2025

DeepHealth brings AI-powered radiology informatics to ECR 2025 in Vienna

DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc., will introduce next-generation AI-powered radiology informatics and population screening solutions at the European Congress of Radiology (ECR) 2025 in Vienna.

3 Mar 2025